纳米医学的最新进展是治疗多发性骨髓瘤的革命性方法
Fatemeh Sadat Shafiei1, Saeid Abroun2
1Department Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran; Department of Biotechnology, Iranian Research Organization for Science & Technology (IROST), Tehran, Iran.
纳米药物为克服多发性骨髓瘤 (MM) 治疗的局限性提供了一个有希望的方法,改善药物输送和减少副作用. 本综述探讨了在MM治疗中增强抗瘤效果的合理纳米药物设计.
科学领域:
- 血液学的恶性瘤
- 癌症纳米医学 癌症纳米医学
- 药物输送系统 药物输送系统
背景情况:
- 多发性骨髓瘤 (MM) 是一种严重的血液性恶性瘤,复发率高,治疗选择有限.
- 目前的治疗方法,如高剂量化疗,显示出有效性,但受到严重的副作用和低于最佳的药物输送的阻碍.
- 迫切需要创新的治疗策略来改善MM患者的治疗结果.
研究的目的:
- 审查合理纳米药物设计的标准,以在MM中获得最佳的抗瘤效果.
- 讨论纳米医学应用在治疗多发性骨髓瘤的最新进展.
- 突出纳米药物作为克服MM当前治疗挑战的潜在解决方案.
主要方法:
- 关于纳米医学在癌症治疗中的现有文献的审查.
- 纳米颗粒所提供的药理动力学和药理动力学改进的分析.
- 讨论针对MM的骨髓微环境的策略.
主要成果:
- 纳米颗粒封装可以增强药物的疗效,延长循环时间,并降低目标外毒性.
- 纳米药物显示出在骨髓微环境内向髓瘤细胞有效传递药物的潜力.
- 合理设计原则对于最大限度地提高纳米药物的治疗效益至关重要.
结论:
- 纳米药物代表了MM常规化疗的有希望的替代品,提供了改进的药物特征.
- 进一步研究纳米医学设计和应用对于推进MM治疗至关重要.
- 通过纳米医学进行向的治疗,有可能克服当前MM疗法的主要局限性.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
